| Previous close | 2.9900 |
| Open | 3.3000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 29.00 |
| Expiry date | 2024-10-18 |
| Day's range | 2.9900 - 3.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Yahoo FinancePfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Pfizer had a surprise beat in its COVID portfolio despite dim forecasts, but the company is still not feeling the love in its stock.
- Yahoo Finance Video
Pfizer raises full-year outlook, stock rises on Q1 beat
Pfizer (PFE) shares tick up in pre-market trading — continuing into the green after the market open — after the pharmaceutical giant raised its full-year profit outlook and topped first-quarter earnings estimates on the top and bottom lines. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Pfizer's outlook on its future product pipeline. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
- GuruFocus.com
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Navigating Post-COVID Challenges ...
Despite a revenue dip, Pfizer boosts EPS guidance and showcases robust oncology growth and strategic FDA approvals.
